Cytokinetics Inc (CYTK)
Fixed asset turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 18,474 | 7,530 | 94,588 | 70,428 | 55,828 |
Property, plant and equipment | US$ in thousands | — | — | 80,453 | 73,271 | 13,346 |
Fixed asset turnover | — | — | 1.18 | 0.96 | 4.18 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $18,474K ÷ $—K
= —
The fixed asset turnover ratio measures how efficiently a company utilizes its fixed assets to generate revenue. Cytokinetics Inc's fixed asset turnover has fluctuated over the years. In December 31, 2020, the ratio stood at 4.18, indicating that the company generated $4.18 in revenue for every $1 invested in fixed assets.
However, there was a significant drop in performance by December 31, 2021, with the ratio falling to 0.96. This suggests that the company's ability to generate revenue from its fixed assets declined.
Subsequently, by December 31, 2022, the ratio improved slightly to 1.18, indicating a modest recovery in the efficiency of utilizing fixed assets to generate revenue.
Unfortunately, there is no data available for December 31, 2023 and December 31, 2024. The missing data prevents us from providing a complete trend analysis for those years.
Overall, the trend in Cytokinetics Inc's fixed asset turnover ratio indicates some volatility in the company's efficiency in utilizing its fixed assets to generate revenue. Further analysis and additional data would be needed to assess the company's performance more accurately.
Peer comparison
Dec 31, 2024